|
Transcriptional Profiling to Define Diffuse Large B Cell Lymphoma Subsets Vulnerable to Targeted and Immune Therapies |
01/06/2025 - 12:00pm to 1:00pm |
|
Leveraging Pan-Tumor Spatial Biology to Predict Immunotherapy Response in Non-Small Cell Lung Cancer |
01/13/2025 - 12:00pm to 1:00pm |
|
Sexual Health in the AYA Population with Cancer |
02/03/2025 - 12:00pm to 1:00pm |
|
Macrophages Unlock the Obesity Paradox of Immunotherapy |
02/10/2025 - 12:00pm to 1:00pm |
|
Enhancing Myeloid Antitumor Activity through Antibody Engineering |
02/17/2025 - 12:00pm to 1:00pm |
|
Precision Medicine Strategies to Activate Innate Immunity in Prostate Cancer |
02/24/2025 - 12:00pm to 1:00pm |
|
The Cancer Moonshot: Health Policy for Improved Cancer Care |
03/10/2025 - 12:00pm to 1:00pm |
|
Fertility Preservation in Patients Receiving Gonadotoxic Cancer Therapies |
03/17/2025 - 12:00pm to 1:00pm |
|
Shepherding in the Next Phase of CAR T-Cell Therapy for Lymphoma |
03/31/2025 - 12:00pm to 1:00pm |
|
Targeting Macrophages for the Treatment of Follicular Lymphoma |
04/28/2025 - 12:00pm to 1:00pm |
Facebook
X
LinkedIn
Forward